Titomic to Deliver Samples under Lockheed Martin & RMIT Research Program
Melbourne-based industrial additive manufacturing company, Titomic Limited, has entered into a commercial research and development agreement with RMIT University (“RMIT”) to be conducted on behalf of Lockheed Martin – a major aerospace and defence company. The study will assess the capabilities of Titomic Kinetic Fusion® (TKF) to create structural satellite parts made from a high-performance metal. Titomic’s participation in this joint research project will analyse the various capabilities of both traditional and additive manufacturing methods relative to radiation shielding within satellites.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201005005042/en/
Titomic Kinetic Fusion® will be used to additively manufacture satellite components. (Photo: Business Wire)
Under this research agreement, Titomic will manufacture high-performance, metal demonstration samples for satellite parts using its industrial-scale additive manufacturing process, Titomic Kinetic Fusion®. This research project may also lead to commercial opportunities for Titomic within the space and defence sectors following the successful validation of the additively manufactured demonstration satellite parts. The small satellite components (cubes) market for commercial and government applications in the main areas of telecommunications, broadcasting, and data communications, with the market size anticipated to grow from USD $4.18B in 2018 to USD $18.30B by 2026, at a CAGR of 20.28%1.
Titomic’s Managing Director Jeff Lang stated:
“Titomic is excited to be involved in this RMIT joint research initiative alongside the global defence and aerospace prime, Lockheed Martin, to provide significant benefit for all involved. As we demonstrate the unique capabilities of Titomic Kinetic Fusion® for the additive manufacture of satellite structures using high-performance metals and super alloys, we are also enabling exponentially faster production to reduce lead-times for the space industry, from months to hours, compared to traditional processes.”
RMIT University’s Professor Milan Brandt stated:
"RMIT Centre for Additive Manufacturing is excited to be working with long term partner Lockheed Martin and Titomic to advance the state of the art in advanced manufacturing methods for protection of satellites from space radiation. The combination of additive manufacturing and highly-dense materials for this application offers new opportunities for not only increased radiation resistance but significantly reduced lead times for manufacture of new satellites."
Visit https://titomic.com/
|
1. |
Fortune Business Insights |
|
|
https://www.fortunebusinessinsights.com/industry-reports/small-satellite-market-101917 |
|
|
|
|
2. |
Australia’sCriticalMineralsStrategy2019 |
|
|
|
|
|
|
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201005005042/en/
Contact information
Peter Vaughan. Ph: +03 9558 8822.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic Dermatitis2.12.2025 13:32:00 EET | Press release
Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate regulatory T cells (Tregs) to restore immune balance, today announced dosing of the first healthy volunteer in the Phase 1 clinical study of EGL-003, an IL‑2⍺-biased mutein designed to selectively activate Tregs while limiting effector T cell stimulation, as a potential treatment for atopic dermatitis. The open-label, multi-center Phase 1 trial begins with a single ascending dose portion in healthy volunteers to rapidly generate foundational safety, pharmacokinetic (PK), and pharmacodynamic (PD) data. These findings will inform dose selection and scheduling for the subsequent multiple ascending dose portion in approximately 40 adults with atopic dermatitis (AD), which will evaluate safety, PK/PD, and early clinical activity versus placebo. Data from both study segments are expected to guide dose selection for a planned Phase 2a trial in AD aimed at establishing clinical pro
AI Takes Center Stage as the Major Threat to Cybersecurity in 20262.12.2025 13:00:00 EET | Press release
Experian® today released its 2026 Data Breach Industry Forecast, offering a look at the evolving cyber threat landscape. The predictions address how the coming year could usher in a new wave of sophisticated attacks driven by artificial intelligence along with other threats and vulnerabilities including quantum computing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202474758/en/ Experian's 2026 Data Breach Industry Forecast Now in its 13th year, the forecast offers six insights into how cybercriminals are leveraging emerging technologies to create more convincing identities, evade detection, and exploit new digital frontiers. From synthetic profiles and autonomous AI agents to shape-shifting malware and even brain-computer interface vulnerabilities, the 2026 predictions point to a future where cyberattacks are more personalized, persistent, and technologically advanced than ever before. To download the complimentary pa
Buro Happold Signs Landmark Agreement with Expo 2030 Riyadh Company to Deliver Detailed Master Plan and Infrastructure and Public Realm Design for Expo 2030 Riyadh2.12.2025 12:00:00 EET | Press release
Buro Happold, a leading global engineering, design and advisory consultancy, has signed a major contract with Expo 2030 Riyadh Company to serve as the lead design consultant for the detailed master plan and detailed design of public realm, landscape, infrastructure and utilities for Expo 2030 Riyadh and its legacy. This partnership represents a significant step toward delivering an event billed as “An Unprecedented World Expo”. Expo 2030 Riyadh is expected to feature nearly 197 participating countries and attract over 42 million visits to Pavilions covering approximately 6 million sqm. The event will offer a unique opportunity for participants to address shared challenges and showcase pioneering solutions for a sustainable future. Under the agreement, Buro Happold will provide comprehensive design and technical services, including, development of the detailed master plan, including a focus on event requirements and legacy phase elements, detailed design of the infrastructure works, uti
ThetaRay Report Warns Europe’s AML System at ‘Breaking Point’ as New Regulations Make AI Adoption Inevitable2.12.2025 12:00:00 EET | Press release
ThetaRay, a global leader in Cognitive AI financial crime compliance, today released a landmark study on the future of anti-money laundering in Europe. The study warns that Europe’s anti-money laundering (AML) system is approaching structural failure, and that financial institutions will be unable to meet upcoming supervisory expectations without advanced AI-driven monitoring and customer screening systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202058684/en/ Next Generation AML Solutions The report, “Next-Generation AML Solutions: An Analysis of AI-Based Tools vis-à-vis the Reform of the European AML Institutional and Substantive Architecture,” offers some of the most comprehensive examinations to date of how the EU’s sweeping AML reform package and the Artificial Intelligence Act will reshape compliance across the region. Co-authored by Prof. Andrea Minto, a leading authority on EU financial regulation at Ca’ Fo
Siren Secures Investment to Advance AI-Driven Investigations for National Security2.12.2025 11:30:00 EET | Press release
Siren, the all-in-one investigation company, today announced a strategic investment from Elastic (NYSE: ESTC), the company behind Elasticsearch. The investment deepens a decade-long partnership between the two companies and accelerates development of Siren’s AI-driven platform, including Siren’s newly launched K9 AI Companion, used by national security, law enforcement, and financial crime agencies worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202354147/en/ Siren, the all-in-one investigation company, today announced a strategic investment from Elastic (NYSE: ESTC), the company behind Elasticsearch. The partnership combines the Elasticsearch Platform, which delivers real-time search, retrieval and anomaly detection across structured, unstructured, and streaming data, with Siren’s patented investigative intelligence technology, which fuses data from multiple sources into explainable, auditable insights. Through
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom